Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REALISE: Safety and Effectiveness of Albendazole-Ivermectin FDC for Helminths
NCT06282315Phase 3Recruiting
- Sponsor
- Insud Pharma
- Start
- Sep 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ivermectin in soil-transmitted helminthiasis (STH), sponsored by Insud Pharma. Started Sep 2025; status: recruiting.
02
Drugs
ivermectin
03
Conditions
soil-transmitted helminthiasis (STH)
Beyond the preview
Go deeper on NCT06282315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282315.